Showing results (651-660 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|March 3, 2022
Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate CancerMichael S Leapman, Michaela Dinan, Saamir Pasha, et al.
JAMA Oncology|June 14, 2019
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Sara M Tolaney, Lee Schwartzberg, et al.
JAMA Oncology|May 10, 2019
Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal CancerYuxuan Wang, Lu Li, Joshua D Cohen, et al.
JAMA Oncology|May 10, 2019
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical TrialMinKe He, QiJiong Li, RuHai Zou, et al.
JAMA Oncology|June 30, 2017
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 DecadesLaura J Esserman, Christina Yau, Carlie K Thompson, et al.
JAMA Oncology|April 6, 2023
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical TrialKevin J Harrington, Robert L Ferris, Maura Gillison, et al.
JAMA Oncology|April 20, 2023
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative ReviewDebra L Richardson, Ramez N Eskander, David M O'Malley
JAMA Oncology|March 30, 2023
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical TrialsDian Wang, Jonathan Harris, William G Kraybill, et al.
JAMA Oncology|March 30, 2023
Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical TrialRoberta Sanfilippo, Nadia Hindi, Josefina Cruz Jurado, et al.
JAMA Oncology|April 1, 2021
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer: A Phase 3 Randomized Clinical TrialJie Wang, Shun Lu, Xinmin Yu, et al.
Pageof 161